Tapewire

Nasdaq · USD

REGN

REGENERON PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
2010
SEC CIK
0000872589
Parsed reports
687

Last 12 months

Inside the activity.

0 purchase rows · 78 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202601
Feb 2026035
Mar 2026013
Apr 202609
May 2026012
Jun 202600
Jul 202601
Aug 202602
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 09, 2021 Filed Dec 10, 2021 22:41 UTC SaleCommon Stock 3,784 $665.00 $2,516,360.00
Disclosure

SEC source: 0001237899-21-000027 · edgardoc.xml · nonDerivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,078

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 09, 2021 Filed Dec 10, 2021 22:41 UTC Exercise / conversionCommon Stock 3,784 $371.40 $1,405,377.60
Disclosure

SEC source: 0001237899-21-000027 · edgardoc.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 09, 2021 Filed Dec 10, 2021 22:37 UTC
Landry Robert EEVP Finance CFO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,250 $0.00 Strike: $399.66 $0.00
Disclosure

SEC source: 0001708138-21-000096 · edgardoc.xml · derivative · entry 21

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,000

Underlying: Common Stock · 4,250 shares

Expires 2024-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F15 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 09, 2021 Filed Dec 10, 2021 22:37 UTC
Landry Robert EEVP Finance CFO
Tax withholdingCommon Stock 3,469 $657.11 $2,279,514.59
Disclosure

SEC source: 0001708138-21-000096 · edgardoc.xml · nonDerivative · entry 3

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,738

F2 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 09, 2021 Filed Dec 10, 2021 22:37 UTC
Landry Robert EEVP Finance CFO
Exercise / conversionCommon Stock 4,250 $399.66 $1,698,555.00
Disclosure

SEC source: 0001708138-21-000096 · edgardoc.xml · nonDerivative · entry 2

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,207

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 09, 2021 Filed Dec 10, 2021 22:30 UTC
LAROSA JOSEPH JEVP General Counsel and Secret
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 30,000 $0.00 Strike: $179.13 $0.00
Disclosure

SEC source: 0001883850-21-000023 · edgardoc.xml · derivative · entry 6

LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2022-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 09, 2021 Filed Dec 10, 2021 22:30 UTC
LAROSA JOSEPH JEVP General Counsel and Secret
Tax withholdingCommon Stock 19,772 $657.11 $12,992,378.92
Disclosure

SEC source: 0001883850-21-000023 · edgardoc.xml · nonDerivative · entry 3

LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,748

Read SEC document
December 09, 2021 Filed Dec 10, 2021 22:30 UTC
LAROSA JOSEPH JEVP General Counsel and Secret
Exercise / conversionCommon Stock 30,000 $179.13 $5,373,900.00
Disclosure

SEC source: 0001883850-21-000023 · edgardoc.xml · nonDerivative · entry 2

LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 23:42 UTC
MURPHY ANDREW JEVP Research
GrantNon-Qualified Stock Option (right to buy) · Derivative 14,783 $0.00 Strike: $644.54 $0.00
Disclosure

SEC source: 0001708138-21-000098 · edgardoc.xml · derivative · entry 22

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,783

Underlying: Common Stock · 14,783 shares

Expires 2031-12-08

F18 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 23:42 UTC
MURPHY ANDREW JEVP Research
GrantCommon Stock 3,462 $0.00 $0.00
Disclosure

SEC source: 0001708138-21-000098 · edgardoc.xml · nonDerivative · entry 1

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,167

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:37 UTC
Landry Robert EEVP Finance CFO
GrantNon-Qualified Stock Option (right to buy) · Derivative 16,958 $0.00 Strike: $644.54 $0.00
Disclosure

SEC source: 0001708138-21-000096 · edgardoc.xml · derivative · entry 22

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,958

Underlying: Common Stock · 16,958 shares

Expires 2031-12-08

F15 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:37 UTC
Landry Robert EEVP Finance CFO
GrantCommon Stock 3,971 $0.00 $0.00
Disclosure

SEC source: 0001708138-21-000096 · edgardoc.xml · nonDerivative · entry 1

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,957

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:36 UTC
Van Plew Daniel PEVP & General Mgr, Industrial
GrantNon-Qualified Stock Option (right to buy) · Derivative 18,548 $0.00 Strike: $644.54 $0.00
Disclosure

SEC source: 0001708138-21-000095 · edgardoc.xml · derivative · entry 3

Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr, Industrial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,548

Underlying: Common Stock · 18,548 shares

Expires 2031-12-08

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:36 UTC
Van Plew Daniel PEVP & General Mgr, Industrial
GrantCommon Stock 4,344 $0.00 $0.00
Disclosure

SEC source: 0001708138-21-000095 · edgardoc.xml · nonDerivative · entry 1

Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr, Industrial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,275

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:35 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 21,198 $0.00 Strike: $644.54 $0.00
Disclosure

SEC source: 0001708138-21-000094 · edgardoc.xml · derivative · entry 6

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,198

Underlying: Common Stock · 21,198 shares

Expires 2031-12-08

F3 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:35 UTC GrantCommon Stock 1,861 $0.00 $0.00
Disclosure

SEC source: 0001708138-21-000094 · edgardoc.xml · nonDerivative · entry 1

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,669

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:35 UTC
STAHL NEILEVP Research and Development
GrantNon-Qualified Stock Option (right to buy) · Derivative 12,494 $0.00 Strike: $644.54 $0.00
Disclosure

SEC source: 0001708138-21-000093 · edgardoc.xml · derivative · entry 4

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,494

Underlying: Common Stock · 12,494 shares

Expires 2031-12-08

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:35 UTC
STAHL NEILEVP Research and Development
GrantCommon Stock 2,926 $0.00 $0.00
Disclosure

SEC source: 0001708138-21-000093 · edgardoc.xml · nonDerivative · entry 1

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,883

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:31 UTC
McCourt MarionEVP Commercial
GrantNon-Qualified Stock Option (right to buy) · Derivative 14,253 $0.00 Strike: $644.54 $0.00
Disclosure

SEC source: 0001883850-21-000024 · edgardoc.xml · derivative · entry 3

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,253

Underlying: Common Stock · 14,253 shares

Expires 2031-12-08

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:31 UTC
McCourt MarionEVP Commercial
GrantCommon Stock 3,338 $0.00 $0.00
Disclosure

SEC source: 0001883850-21-000024 · edgardoc.xml · nonDerivative · entry 1

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,376

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:30 UTC
LAROSA JOSEPH JEVP General Counsel and Secret
GrantNon-Qualified Stock Option (right to buy) · Derivative 14,253 $0.00 Strike: $644.54 $0.00
Disclosure

SEC source: 0001883850-21-000023 · edgardoc.xml · derivative · entry 7

LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,253

Underlying: Common Stock · 14,253 shares

Expires 2031-12-08

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:30 UTC
LAROSA JOSEPH JEVP General Counsel and Secret
GrantCommon Stock 3,338 $0.00 $0.00
Disclosure

SEC source: 0001883850-21-000023 · edgardoc.xml · nonDerivative · entry 1

LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,520

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:28 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 7,941 $0.00 Strike: $644.54 $0.00
Disclosure

SEC source: 0001883850-21-000022 · edgardoc.xml · derivative · entry 8

Fenimore Christopher R. · CIK 0001697422 · SVP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,941

Underlying: Common Stock · 7,941 shares

Expires 2031-12-08

F3 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 22:28 UTC GrantCommon Stock 1,859 $0.00 $0.00
Disclosure

SEC source: 0001883850-21-000022 · edgardoc.xml · nonDerivative · entry 1

Fenimore Christopher R. · CIK 0001697422 · SVP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,392

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.

Read SEC document
December 03, 2021 Filed Dec 6, 2021 21:10 UTC
STAHL NEILEVP Research and Development
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 72,500 $0.00 Strike: $179.13 $0.00
Disclosure

SEC source: 0001883850-21-000018 · edgardoc.xml · derivative · entry 6

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 72,500 shares

Expires 2022-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 03, 2021 Filed Dec 6, 2021 21:10 UTC
STAHL NEILEVP Research and Development
Tax withholdingCommon Stock 50,352 $632.45 $31,845,122.40
Disclosure

SEC source: 0001883850-21-000018 · edgardoc.xml · nonDerivative · entry 3

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,957

Read SEC document
December 03, 2021 Filed Dec 6, 2021 21:10 UTC
STAHL NEILEVP Research and Development
Exercise / conversionCommon Stock 72,500 $179.13 $12,986,925.00
Disclosure

SEC source: 0001883850-21-000018 · edgardoc.xml · nonDerivative · entry 2

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,309

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 6 $641.23 $3,847.38
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 12

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,491

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F10 · price: Represents volume-weighted average price of sales of 6 shares of Company stock on December 1, 2021 at prices ranging from $641.01 to $641.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 5 $640.47 $3,202.35
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 11

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,497

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F9 · price: Represents volume-weighted average price of sales of 5 shares of Company stock on December 1, 2021 at prices ranging from $640.01 to $640.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 24 $639.49 $15,347.76
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 10

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,502

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F8 · price: Represents volume-weighted average price of sales of 24 shares of Company stock on December 1, 2021 at prices ranging from $639.01 to $639.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 12 $638.62 $7,663.44
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 9

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,526

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F7 · price: Represents volume-weighted average price of sales of 12 shares of Company stock on December 1, 2021 at prices ranging from $638.03 to $638.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 22 $637.75 $14,030.50
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 8

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,538

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F6 · price: Represents volume-weighted average price of sales of 22 shares of Company stock on December 1, 2021 at prices ranging from $637.17 to $637.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 1 $636.50 $636.50
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 7

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,560

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 9 $635.36 $5,718.24
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 6

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,561

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F5 · price: Represents volume-weighted average price of sales of 9 shares of Company stock on December 1, 2021 at prices ranging from $635.06 to $635.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 11 $634.56 $6,980.16
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 5

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,570

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F4 · price: Represents volume-weighted average price of sales of 11 shares of Company stock on December 1, 2021 at prices ranging from $634.05 to $634.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 2 $633.47 $1,266.94
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 4

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,581

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3 · price: Represents volume-weighted average price of sales of 2 shares of Company stock on December 1, 2021 at prices ranging from $633.21 to $633.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 7 $632.63 $4,428.41
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 3

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,583

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · price: Represents volume-weighted average price of sales of 7 shares of Company stock on December 1, 2021 at prices ranging from $632.00 to $632.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:07 UTC SaleCommon Stock 1 $631.15 $631.15
Disclosure

SEC source: 0001883850-21-000016 · edgardoc.xml · nonDerivative · entry 2

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,590

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:04 UTC
McCourt MarionEVP Commercial
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,000 $0.00 Strike: $342.93 $0.00
Disclosure

SEC source: 0001883850-21-000014 · edgardoc.xml · derivative · entry 4

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 1,000 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:04 UTC
McCourt MarionEVP Commercial
SaleCommon Stock 1,000 $639.13 $639,130.00
Disclosure

SEC source: 0001883850-21-000014 · edgardoc.xml · nonDerivative · entry 2

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,038

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:04 UTC
McCourt MarionEVP Commercial
Exercise / conversionCommon Stock 1,000 $342.93 $342,930.00
Disclosure

SEC source: 0001883850-21-000014 · edgardoc.xml · nonDerivative · entry 1

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,038

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
November 29, 2021 Filed Dec 6, 2021 21:10 UTC
STAHL NEILEVP Research and Development
GiftCommon Stock 4,605 $0.00 $0.00
Disclosure

SEC source: 0001883850-21-000018 · edgardoc.xml · nonDerivative · entry 4

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Indirect · by Spouse as Trustee

Disclosed balance after: 4,605

Read SEC document
November 29, 2021 Filed Dec 6, 2021 21:10 UTC
STAHL NEILEVP Research and Development
GiftCommon Stock 4,605 $0.00 $0.00
Disclosure

SEC source: 0001883850-21-000018 · edgardoc.xml · nonDerivative · entry 1

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,809

Read SEC document
November 22, 2021 Filed Nov 23, 2021 21:29 UTC SaleCommon Stock 1,000 $660.00 $660,000.00
Disclosure

SEC source: 0001883850-21-000012 · edgardoc.xml · nonDerivative · entry 3

SING GEORGE L · CIK 0001225471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,858

Read SEC document
November 22, 2021 Filed Nov 23, 2021 21:29 UTC SaleCommon Stock 1,000 $655.00 $655,000.00
Disclosure

SEC source: 0001883850-21-000012 · edgardoc.xml · nonDerivative · entry 2

SING GEORGE L · CIK 0001225471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,858

Read SEC document
November 19, 2021 Filed Nov 19, 2021 22:50 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 239,063 $0.00 Strike: $270.43 $0.00
Disclosure

SEC source: 0001883850-21-000009 · edgardoc.xml · derivative · entry 9

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 239,063 shares

Expires 2023-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
November 19, 2021 Filed Nov 19, 2021 22:50 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 281,250 $0.00 Strike: $179.13 $0.00
Disclosure

SEC source: 0001883850-21-000009 · edgardoc.xml · derivative · entry 8

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 281,250 shares

Expires 2022-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
November 19, 2021 Filed Nov 19, 2021 22:50 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Tax withholdingCommon Stock 185,646 $651.96 $121,033,766.16
Disclosure

SEC source: 0001883850-21-000009 · edgardoc.xml · nonDerivative · entry 4

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 465,922

Read SEC document
November 19, 2021 Filed Nov 19, 2021 22:50 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Exercise / conversionCommon Stock 281,250 $179.13 $50,380,312.50
Disclosure

SEC source: 0001883850-21-000009 · edgardoc.xml · nonDerivative · entry 3

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 651,568

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 19, 2021 Filed Nov 19, 2021 22:50 UTC
SCHLEIFER LEONARD SDirector · President & CEO
Tax withholdingCommon Stock 173,491 $651.96 $113,109,192.36
Disclosure

SEC source: 0001883850-21-000009 · edgardoc.xml · nonDerivative · entry 2

SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,318

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.